Expression of heparanase gene in eutopic and ectopic endometrium of women with endometriosis

In: Chin J Obstet Gynecol · 2004 · vol. 39(01) , pp. 24–26 · doi:10.3760/j.issn:0529-567x.2004.01.009 · W3031485591
OA: closed CC0 ⤵ 1 in-corpus citation
Full text JSON View on OpenAlex View at publisher
⚙ AI-generated summary by qwen3.7-flash, 2026-09-04 ⓘ

This study found significantly higher heparanase mRNA expression in both eutopic and ectopic endometrium of women with endometriosis compared to controls, suggesting a role in disease pathogenesis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-10-03 · read from full text ⓘ

This study investigated the expression of heparanase gene mRNA in both eutopic and ectopic endometrial tissues from women diagnosed with endometriosis. Using in situ hybridization, researchers compared 23 patients with endometriosis against a control group of 25 healthy women to assess mRNA positivity rates across different menstrual phases. The results showed significantly higher heparanase mRNA expression in the endometriosis group compared to controls, with intense staining observed specifically in ectopic lesions. The authors concluded that this overexpression is linked to disease pathogenesis and may serve as a potential therapeutic target. This paper is centrally about endometriosis — specifically examining molecular markers in eutopic and ectopic endometrial tissue to understand disease mechanisms.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

目的 研究乙酰肝素酶基因在子宫内膜异位症发病中的作用.方法应用原位杂交技术,检测腹腔镜手术中证实为子宫内膜异位症患者(EM组,23例)的在位和异位子宫内膜组织乙酰肝素酶mRNA的表达,并与正常妇女(对照组,25例)子宫内膜组织比较.结果 (1) EM组在位与异位子宫内膜乙酰肝素酶mRNA阳性表达率一致,但异位子宫内膜组织中,阳性细胞着色较深.在位子宫内膜腺上皮细胞较间质细胞胞浆染色深,异位子宫内膜腺上皮细胞与间质细胞胞浆着色基本一致;EM组增生期与分泌期子宫内膜均有乙酰肝素酶mRNA的表达,增生期阳性表达率为83.3%(10/12);分泌期为72.7%(8/11),两者比较,差异也无显著性(P>0.05);(2)对照组增生期子宫内膜乙酰肝素酶mRNA的阳性表达率为41.7%(5/12),分泌期子宫内膜阳性表达率为7.7 %(1/13),两者比较,差异有显著性(P<0.05).(3)EM组子宫内膜乙酰肝素酶mRNA阳性表达率为78.3%(18/23); 对照组为24.0%(6/25),两者比较,差异也有显著性(P<0.05).结论乙酰肝素酶基因的表达与子宫内膜异位症的发病相关,其可能成为子宫内膜异位症治疗的一个有价值的靶点。
Full text 708 characters · extracted from oa-doi-fallback · click to expand
乙酰肝素酶基因在子宫内膜异位症患者在位与异位子宫内膜组织中的表达 Expression of heparanase gene in eutopic and ectopic endometrium of women with endometriosis 摘要目的研究乙酰肝素酶基因在子宫内膜异位症发病中的作用.方法应用原位杂交技术,检测腹腔镜手术中证实为子宫内膜异位症患者(EM组,23例)的在位和异位子宫内膜组织乙酰肝素酶mRNA的表达,并与正常妇女(对照组,25例)子宫内膜组织比较.结果 (1) EM组在位与异位子宫内膜乙酰肝素酶mRNA阳性表达率一致,但异位子宫内膜组织中,阳性细胞着色较深.在位子宫内膜腺上皮细胞较间质细胞胞浆染色深,异位子宫内膜腺上皮细胞与间质细胞胞浆着色基本一致;EM组增生期与分泌期子宫内膜均有乙酰肝素酶mRNA的表达,增生期阳性表达率为83.3%(10/12);分泌期为72.7%(8/11),两者比较,差异也无显著性(P>0.05);(2)对照组增生期子宫内膜乙酰肝素酶mRNA的阳性表达率为41.7%(5/12),分泌期子宫内膜阳性表达率为7.7 %(1/13),两者比较,差异有显著性(P<0.05).(3)EM组子宫内膜乙酰肝素酶mRNA阳性表达率为78.3%(18/23); 对照组为24.0%(6/25),两者比较,差异也有显著性(P<0.05).结论乙酰肝素酶基因的表达与子宫内膜异位症的发病相关,其可能成为子宫内膜异位症治疗的一个有价值的靶点. 更多相关知识 - 浏览257 - 被引11 - 下载12 相似文献 - 中文期刊 - 外文期刊 - 学位论文 - 会议论文

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK